Signet Healthcare Partners Provides Growth Equity to Ascendia Pharmaceuticals

April 8, 2021

Signet Healthcare Partners, a New York-based growth equity firm, has made a growth equity investment in Ascendia Pharmaceuticals, a North Brunswick, New Jersey-based specialty CDMO. The proceeds will fund Ascendia's facility expansion and increased manufacturing capacity; Signet principals James Gale and Dr. Theron Odlaug will join Ascendia's board.

Targets
Ascendia Pharmaceuticals, Inc.
Industry
Pharmaceuticals
Location
New Jersey, United States
Transaction Type
Growth capital

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.